ICD-10 Code C83.3A | Diffuse large B-cell lymphoma, in remission Symptoms, Diagnosis, Billing

Diffuse large B-cell lymphoma (DLBCL) is a type of non-Hodgkin lymphoma characterized by the rapid proliferation of large B-cells. It is the most common subtype of lymphoma and can arise in lymph nodes or extranodal sites. The designation 'in remission' indicates that the disease is currently not detectable following treatment. Accurate coding with ICD-10 Code C83.3A is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate follow-up care.

What is ICD-10 Code C83.3A for Diffuse large B-cell lymphoma, in remission?

ICD-10 Code C83.3A specifically denotes Diffuse large B-cell lymphoma that is currently in remission. This code is utilized when a patient has undergone treatment and shows no signs of active disease. It is crucial for clinical documentation and billing to reflect the patient's current health status accurately, facilitating appropriate management and follow-up care.

ICD-10 Code C83.3A – Clinical Definition and Explanation of Diffuse large B-cell lymphoma, in remission

Diffuse large B-cell lymphoma is a malignant neoplasm of B-lymphocytes that can progress rapidly if untreated. The condition requires prompt medical intervention, including chemotherapy or radiation therapy. Remission indicates a significant reduction or absence of disease symptoms, necessitating ongoing monitoring for potential relapse.

Key Clinical Features:

• Rapidly enlarging lymph nodes, often in the neck, axilla, or abdomen.
• B-symptoms such as fever, night sweats, and weight loss.
• Extranodal involvement, which may include the gastrointestinal tract or central nervous system.
• Diagnosis confirmed through biopsy and histopathological examination.

ICD-10 Code C83.3A for Diffuse large B-cell lymphoma, in remission – SOAP Notes & Clinical Use

ICD-10 Code C83.3A is integral in SOAP notes for documenting the patient's remission status. It aids in capturing the patient's symptoms, assessment findings, and treatment plans, ensuring comprehensive care in both acute and chronic settings.

What Does ICD-10 Code C83.3A for Diffuse large B-cell lymphoma, in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C83.3A connects subjective reports of symptoms and objective clinical findings to a formal diagnosis of remission. This coding supports continuity of care, facilitates accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code C83.3A – Diffuse large B-cell lymphoma, in remission

Management of Diffuse large B-cell lymphoma in remission focuses on monitoring and supportive care to prevent relapse.

Antibiotic Therapy:

• Not applicable as DLBCL is not an infectious disease; however, prophylactic antibiotics may be considered in immunocompromised patients.

Supportive Care:

• Regular follow-up appointments for monitoring.
• Management of potential late effects of treatment.
• Psychosocial support for emotional well-being.

Infection Control:

• Standard precautions to prevent infections, especially in immunocompromised patients.
• Vaccination updates as per guidelines.

How to Document Symptoms of Diffuse large B-cell lymphoma, in remission (ICD-10 C83.3A) in SOAP Notes

Subjective:

• Patient reports feeling well with no current symptoms.
• Denies fever, night sweats, or weight loss.
• History of previous treatment for DLBCL.

Objective:

• Physical examination shows no palpable lymphadenopathy.
• Vital signs within normal limits.
• Recent imaging studies show no evidence of disease.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Diffuse large B-cell lymphoma, in remission (ICD-10 Code C83.3A)

Assessment:

• Diffuse large B-cell lymphoma, in remission (ICD-10 Code C83.3A).
• No current symptoms or signs of disease.
• Regular follow-up recommended to monitor for relapse.

Plan:

• Continue routine follow-up every 3-6 months.
• Educate patient on signs of relapse.
• Consider imaging studies as needed based on clinical judgment.

Treatment & Plan Section for ICD-10 Code C83.3A – Diffuse large B-cell lymphoma, in remission

• Monitor for signs of relapse through regular follow-ups.
• Provide education on lifestyle modifications to support health.
• Encourage participation in support groups for emotional health.
• Schedule imaging studies as clinically indicated.

Using ICD-10 Code C83.3A for Diffuse large B-cell lymphoma, in remission in Billing & SOAP Note Compliance

• Ensure accurate documentation of remission status in the patient's record.
• Use C83.3A in conjunction with relevant CPT codes for billing.
• Document any symptoms or findings that support the diagnosis.
• Align treatment plans with clinical guidelines to justify billing.

Related ICD-10 Codes Often Used with Diffuse large B-cell lymphoma, in remission

ICD-10 Code C83.3A in Medical Billing and Insurance for Diffuse large B-cell lymphoma, in remission

ICD-10 Code C83.3A is critical for accurate billing in hospital, ER, or oncology settings.

Billing Notes:

• Document the patient's remission status clearly in the medical record.
• Use C83.3A in appropriate clinical settings to support claims.
• Include relevant clinical findings and treatment plans in documentation.

Common CPT Pairings: